Effects of polymorphisms of the sex hormone-binding globulin (SHBG) gene on free estradiol and bone mineral density

Bone

Volumn 45, Issue 6, 2009, Pages 1169-1174

  Napoli, Nicola ^a,b   Varadharajan, Ana ^c,d   Rini, Giovam Batista ^e   Del Fiacco, Romano ^e   Yarramaneni, Jayasree ^a   Mumm, Steven ^a   Villareal, Dennis T ^a   Armamento Villareal, Reina ^a,f  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^c ST LUKE S HOSPITAL   (United States)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e UNIVERSITY OF PALERMO   (Italy)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

bone mineral density; free estradiol; osteoporosis; sex hormone binding globulin

Indexed keywords

ADENINE; ASPARAGINE; ASPARTIC ACID; ESTRADIOL; GUANINE; SEX HORMONE BINDING GLOBULIN;

5' UNTRANSLATED REGION; ADULT; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; BONE DENSITY; CAUCASIAN; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; FEMUR; GENETIC VARIABILITY; GENOTYPE; HIP; HORMONE BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; MENSTRUAL CYCLE; NORMAL HUMAN; POSTMENOPAUSE;

5' UNTRANSLATED REGIONS; BONE DENSITY; ESTRADIOL; FEMALE; GENOTYPE; HUMANS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SEX HORMONE-BINDING GLOBULIN;

EID: 70350214361     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2009.08.001     Document Type: Article

References (37)

1. Rosner W. The functions of corticosteroid-binding globulin and sex hormone-binding globulin: recent advances. Endocr. Rev. 11 1 (1990) 80-91
2. Hammond G.L. Potential functions of plasma steroid-binding proteins. Trends Endocrinol. Metab. 6 9-10 (1995) 298-304
3. Toniolo P.G., Levitz M., Zeleniuch-Jacquotte A., et al. A prospective study of endogenous estrogens and breast cancer in postmenopausal women. J. Natl. Cancer Inst. 87 3 (1995) 190-197
4. Berrino F., Muti P., Micheli A., et al. Serum sex hormone levels after menopause and subsequent breast cancer. J. Natl. Cancer Inst. 88 5 (1996) 291-296
5. van Hemert A.M., Birkenhager J.C., de Jong F.H., Vandenbroucke J.P., and Valkenburg H.A. Sex hormone binding globulin in postmenopausal women: a predictor of osteoporosis superior to endogenous oestrogens. Clin. Endocrinol. (Oxf) 31 4 (1989) 499-509
6. Stone K., Bauer D.C., Black D.M., Sklarin P., Ensrud K.E., and Cummings S.R. Hormonal predictors of bone loss in elderly women: a prospective study. The Study of Osteoporotic Fractures Research Group. J. Bone Miner. Res. 13 7 (1998) 1167-1174
7. Slemenda C., Longcope C., Peacock M., Hui S., and Johnston C.C. Sex steroids, bone mass, and bone loss. A prospective study of pre-, peri-, and postmenopausal women. J. Clin. Invest. 97 1 (1996) 14-21
8. Zeleniuch-Jacquotte A., Shore R.E., Koenig K.L., et al. Postmenopausal levels of oestrogen, androgen, and SHBG and breast cancer: long-term results of a prospective study. Br. J. Cancer 90 1 (2004) 153-159
9. Goderie-Plomp H.W., van der K.M., de R.W., Hofman A., de Jong F.H., and Pols H.A. Endogenous sex hormones, sex hormone-binding globulin, and the risk of incident vertebral fractures in elderly men and women: the Rotterdam Study. J. Clin. Endocrinol. Metab. 89 7 (2004) 3261-3269
10. Dunning A.M., Dowsett M., Healey C.S., et al. Polymorphisms associated with circulating sex hormone levels in postmenopausal women. J. Natl. Cancer Inst. 96 12 (2004) 936-945
11. Cousin P., Dechaud H., Grenot C., Lejeune H., Hammond G.L., and Pugeat M. Influence of glycosylation on the clearance of recombinant human sex hormone-binding globulin from rabbit blood. J. Steroid Biochem. Mol. Biol. 70 4-6 (1999) 115-121
12. Cousin P., Calemard-Michel L., Lejeune H., et al. Influence of SHBG gene pentanucleotide TAAAA repeat and D327N polymorphism on serum sex hormone-binding globulin concentration in hirsute women. J. Clin. Endocrinol. Metab. 89 2 (2004) 917-924
13. Becchis M., Frairia R., Ferrera P., et al. The additionally glycosylated variant of human sex hormone-binding globulin (SHBG) is linked to estrogen-dependence of breast cancer. Breast Cancer Res. Treat. 54 2 (1999) 101-107
14. Cui Y., Shu X.O., Cai Q., et al. Association of breast cancer risk with a common functional polymorphism (Asp327Asn) in the sex hormone-binding globulin gene. Cancer Epidemiol. Biomarkers Prev. 14 5 (2005) 1096-1101
15. Forsti A., Jin Q., Grzybowska E., et al. Sex hormone-binding globulin polymorphisms in familial and sporadic breast cancer. Carcinogenesis 23 8 (2002) 1315-1320
16. Eriksson A.L., Lorentzon M., Mellstrom D., et al. SHBG gene promoter polymorphisms in men are associated with serum sex hormone-binding globulin, androgen and androgen metabolite levels, and hip bone mineral density. J. Clin. Endocrinol. Metab. 91 12 (2006) 5029-5037
17. Riancho J.A., Valero C., Zarrabeitia M.T., Garcia-Unzueta M.T., Amado J.A., and Gonzalez-Macias J. Genetic polymorphisms are associated with serum levels of sex hormone binding globulin in postmenopausal women. BMC Med. Genet. 9 (2008) 112
18. Armamento-Villareal R., Villareal D.T., Avioli L.V., and Civitelli R. Estrogen status and heredity are major determinants of premenopausal bone mass. J. Clin. Invest. 90 6 (1992) 2464-2471
19. Napoli N., Villareal D.T., Mumm S., et al. Effect of CYP1A1 gene polymorphisms on estrogen metabolism and bone density. J. Bone Miner. Res. 20 2 (2005) 232-239
20. Armamento-Villareal R.C., Napoli N., Klug T., and Civitelli R. The oxidative metabolism of estrogen modulates response to ERT/HRT in postmenopausal women. Bone 35 3 (2004) 682-688
21. Haiman C.A., Riley S.E., Freedman M.L., Setiawan V.W., Conti D.V., and Le M.L. Common genetic variation in the sex steroid hormone-binding globulin (SHBG) gene and circulating SHBG levels among postmenopausal women: the Multiethnic Cohort. J. Clin. Endocrinol. Metab. 90 4 (2005) 2198-2204
22. Khosla S., Melton III L.J., and Riggs B.L. Clinical review 144: estrogen and the male skeleton. J. Clin. Endocrinol. Metab. 87 4 (2002) 1443-1450
23. Wu F., Ames R., Evans M.C., France J.T., and Reid I.R. Determinants of sex hormone-binding globulin in normal postmenopausal women. Clin. Endocrinol. (Oxf) 54 1 (2001) 81-87
24. Haffner S.M., Katz M.S., and Dunn J.F. Increased upper body and overall adiposity is associated with decreased sex hormone binding globulin in postmenopausal women. Int. J. Obes. 15 7 (1991) 471-478
25. Gambera A., Scagliola P., Falsetti L., Sartori E., and Bianchi U. Androgens, insulin-like growth factor-I (IGF-I), and carrier proteins (SHBG, IGFBP-3) in postmenopause. Menopause 11 2 (2004) 159-166
26. Bataille V., Perret B., Evans A., et al. Sex hormone-binding globulin is a major determinant of the lipid profile: the PRIME study. Atherosclerosis 179 2 (2005) 369-373
27. Kalme T., Seppala M., Qiao Q., et al. Sex hormone-binding globulin and insulin-like growth factor-binding protein-1 as indicators of metabolic syndrome, cardiovascular risk, and mortality in elderly men. J. Clin. Endocrinol. Metab. 90 3 (2005) 1550-1556
28. Mikulec K.H., Holloway L., Krasnow R.E., et al. Relationship of endogenous sex hormones to coronary heart disease: a twin study. J. Clin. Endocrinol. Metab. 89 3 (2004) 1240-1245
29. Paoletti A.M., Congia S., Lello S., et al. Low androgenization index in elderly women and elderly men with Alzheimer's disease. Neurology 62 2 (2004) 301-303
30. Cummings S.R., Browner W.S., Bauer D., et al. Endogenous hormones and the risk of hip and vertebral fractures among older women. Study of Osteoporotic Fractures Research Group. N. Engl. J. Med. 339 11 (1998) 733-738
31. Kaaks R., Rinaldi S., Key T.J., et al. Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. Endocr. Relat. Cancer 12 4 (2005) 1071-1082
32. Xita N., Tsatsoulis A., Chatzikyriakidou A., and Georgiou I. Association of the (TAAAA)n repeat polymorphism in the sex hormone-binding globulin (SHBG) gene with polycystic ovary syndrome and relation to SHBG serum levels. J. Clin. Endocrinol. Metab. 88 12 (2003) 5976-5980
33. Hogeveen K.N., Cousin P., Pugeat M., Dewailly D., Soudan B., and Hammond G.L. Human sex hormone-binding globulin variants associated with hyperandrogenism and ovarian dysfunction. J. Clin. Invest. 109 7 (2002) 973-981
34. Khosla S. Editorial: Sex hormone binding globulin: inhibitor or facilitator (or both) of sex steroid action?. J. Clin. Endocrinol. Metab. 91 12 (2006) 4764-4766
35. Freedman M.L., Reich D., Penney K.L., et al. Assessing the impact of population stratification on genetic association studies. Nat. Genet. 36 4 (2004) 388-393
36. Wacholder S., Rothman N., and Caporaso N. Population stratification in epidemiologic studies of common genetic variants and cancer: quantification of bias. J. Natl. Cancer Inst. 92 14 (2000) 1151-1158
37. Hammes A., Andreassen T.K., Spoelgen R., et al. Role of endocytosis in cellular uptake of sex steroids. Cell 122 5 (2005) 751-762